Who
Jason Matuszewski
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, BioStem Technologies.
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Sep 2026
- Last trade
- 7 Oct 2026
- Last filed
- 9 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Oct 2026filed 9 Oct 2026 | BSEM BioStem TechnologiesBiotechnology | SEC FORM 4 Code M | $500K250,000 at $2.00 | filing |
| 7 Oct 2026filed 9 Oct 2026 | BSEM BioStem Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code M | —250,000 at $0.00 | filing |
| 17 Sep 2026filed 17 Sep 2026 | BSEM BioStem TechnologiesBiotechnology | SEC FORM 4 Code M | —16,650 at $0.00 | filing |
| 17 Sep 2026filed 17 Sep 2026 | BSEM BioStem Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code M | —16,650 at $0.00 | filing |
| 17 Sep 2026filed 17 Sep 2026 | BSEM BioStem Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code M | —16,650 at $0.00 | filing |
| 17 Sep 2026filed 17 Sep 2026 | BSEM BioStem TechnologiesBiotechnology | SEC FORM 4 Code M | —16,650 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | BSEM BioStem TechnologiesBiotechnology | SEC FORM 4 Code M | —8,469 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | BSEM BioStem Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code M | —8,469 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | BSEM BioStem Technologiesoption or derivative · Biotechnology | SEC FORM 4 Code M | —8,469 at $0.00 | filing |
| 15 Sep 2026filed 17 Sep 2026 | BSEM BioStem TechnologiesBiotechnology | SEC FORM 4 Code M | —8,469 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.